Mahro Ershadi
CHIEF PHARMACY AND STRATEGY OFFICER at CHASE BREXTON HEALTH SERVICES INC · MD · Disease Research
$337K
Peak Total Compensation
5
Years Tracked
4x
vs. Median Household
Mahro Ershadi has appeared in compensation disclosures over 5 years of available data (2021–2025). Total compensation changed from $255,956 to $336,566 - a 31.5% increase.
Peak total compensation of $336,566 equals 4x the median U.S. household income ($75,000).
Compensation History
Year-by-Year Detail
| Year | Organization | Title | Compensation | Other | Total |
|---|---|---|---|---|---|
| 2025 | CHASE BREXTON HEALTH SERVICES INC | CHIEF PHARMACY AND STRATEGY OFFICER | $321,736 | $14,830 | $336,566 |
| 2024 | CHASE BREXTON HEALTH SERVICES INC | CHIEF PHARMACY AND STRATEGY OFFICER | $312,569 | $14,747 | $327,316 |
| 2023 | CHASE BREXTON HEALTH SERVICES INC | CHIEF PHARMACY & STRATEGY OFFICER | $305,343 | $14,303 | $319,646 |
| 2022 | CHASE BREXTON HEALTH SERVICES INC | VP, PHARMACY, STRATEGY & BUS DEV | $307,209 | $4,378 | $311,587 |
| 2021 | CHASE BREXTON HEALTH SERVICES INC | VP, PHARMACY, STRATEGY & BUS DEV | $255,229 | $727 | $255,956 |
Peers at CHASE BREXTON HEALTH SERVICES INC
| Name | Title | Peak Comp. |
|---|---|---|
| Patrick Mutch | CEO | $594K |
| Richard Larison | FORMER CEO | $484K |
| Sebastian Ruhs | CMO | $383K |
| Bruce Gneshin | DIRECTOR, OB/GYN | $377K |
| Eric Turnbaugh | CFO | $370K |
| Nziavake Masimasi | SITE MEDICAL DIRECTOR | $333K |
| Earl Horton | PHYSICIAN | $316K |
| Sharon Bisco | DIRECTOR, PSYCHIATRY | $313K |
| Alice Sliwka | CHIEF OPERATING AND QUALITY OFFICER | $309K |
| Michelle Barrera | CHIEF OPERATING OFFICER | $309K |
Email Alerts
Get notified about Mahro Ershadi
Get an email when a new IRS Form 990 filing is posted that includes this executive. We send a confirmation link first - we don't add you to any other list.
Compare with another executive: Open comparison tool →